Skip to main content

Market Overview

Pandemic Hits Perrigo Q1 Top And Bottomline

Pandemic Hits Perrigo Q1 Top And Bottomline
  • Perrigo Company plc (NYSE: PRGOreported Q1 net sales were $1.01 billion, a decrease of 6.8% year-on-year, missing the consensus of $1.02 billion.
  • Adjusted diluted EPS fell 25.4% to $0.50, well below the consensus of $0.57.
  • The reported declines in the first quarter were distorted by consumer pantry loading in the year-ago quarter and by a historically weak cough/cold season this year, both of which resulted from COVID-19.
  • Consumer Self-Care Americas segment Q1 net sales of $641 million were 8.6% lower than the prior-year quarter, with organic growth down 11.8%.
  • Consumer Self-Care International segment sales decreased 3.4% Y/Y to $370 million, with organic growth down 9.1%.
  • Operating income of $51 million fell from $86 million a year ago. Adjusted operating income came in at $118 million, lower than $151 million last year.
  • The results were impacted by lower net sales volumes leading to lower gross profit, divestitures, and higher operating expenses, including R&D investments.
  • Guidance: Perrigo reaffirmed its FY21 outlook and expected to deliver 3% organic net sales growth, 5% adjusted operating income growth.
  • It sees adjusted EPS of $2.50 to $2.70, in line with the consensus of $2.62.
  • Price Action: PRGO shares are up 0.5% at $43.34 during the premarket trading on the last check Tuesday.

Related Articles (PRGO)

View Comments and Join the Discussion!

Posted-In: BriefsBiotech Earnings News Guidance Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at